Somaxon Pharma On Vigil

in Gold Holdings Gold Investing by admin — November 30, 2009 9:55 pm | no comments

With the FDA decision date of December 4 looming for Somaxon Pharmaceuticals Inc. (SOMX)’s amended New Drug Application for Silenor for treatment of insomnia, the stock set a new intraday high of $4.80 for the year Monday before settling down at $3. Somaxon Pharma On Vigil

Read the original here:
Somaxon Pharma On Vigil

Tags: application before-settling Gold new-intraday pharma somaxon somaxon-pharma somaxon-pharmaceuticals stock the-stock vigil year